# Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers

> **NCT01383096** · PHASE1 · COMPLETED · sponsor: **Medicines for Malaria Venture** · enrollment: 52 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** OZ439 mesylate 800mg Powder in Bottle for Oral Suspension
- **DRUG:** OZ439 mesylate 400mg Prototype Solution Formula 1
- **DRUG:** OZ439 mesylate 800mg Prototype Solution Formula 1
- **DRUG:** OZ439 mesylate 800mg Prototype Solution Formula 2

## Key facts

- **NCT ID:** NCT01383096
- **Lead sponsor:** Medicines for Malaria Venture
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2015-01-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01383096

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01383096, "Study To Investigate The Relative Bioavailability of OZ439 Formulations In Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01383096. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*